Innovative Nanoplatforms for Enhanced Gene Delivery and Therapeutic Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (20 February 2025) | Viewed by 1166
Special Issue Editor
Interests: biomacromolecules; cancer therapy; drug resistance; drug controlled release; bionanomaterials; artificial cell
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue delves into the cutting-edge advancements in nanotechnology, emphasizing the development and application of novel nanoplatforms for gene delivery and therapeutic interventions. As gene delivery systems evolve from traditional vectors to sophisticated nanostructures, these innovations promise enhanced delivery efficiency, targeted specificity, and improved safety profiles.
Key areas of focus include the design and synthesis of advanced nanomaterials such as lipid-based nanoparticles, polymeric nanocarriers, and hybrid nanocomposites. Mechanistic studies will shed light on cellular uptake, intracellular trafficking, and gene expression facilitated by these nanoplatforms. Therapeutic applications will cover the treatment of genetic disorders, cancers, and overcoming chemoresistance through targeted gene delivery. Moreover, evaluations of biocompatibility, toxicity, and therapeutic efficacy will ensure the safety and effectiveness of these nanoplatforms.
This Special Issue aims to provide a comprehensive overview of the current innovations and future trends in nanotechnology-based gene delivery and therapeutic applications, inviting contributions that push the boundaries of current research and offer new insights into this rapidly evolving field.
I look forward to receiving your contributions.
Prof. Dr. Hongjing Dou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnology
- gene delivery
- genetic disorders
- enhanced delivery
- gene expression
- targeted therapeutics
- cancers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
